TY - JOUR
T1 - Nephron-Sparing Surgery for Renal Cell Carcinoma
T2 - State of the Art and 10 Years of Multicentric Experience
AU - Martorana, Giuseppe
AU - Bertaccini, Alessandro
AU - Concetti, Sergio
AU - Franceschelli, Alessandro
AU - Schiavina, Riccardo
AU - Severini, Enrico
AU - Sanguedolce, Francesco
AU - Giberti, Claudio
AU - Belgrano, Emanuele
AU - Carmignani, Giorgio
PY - 2006/6
Y1 - 2006/6
N2 - Objectives: The natural history of renal cell carcinoma (RCC) has changed dramatically in the last two decades. The rising incidence of small renal lesions and advances in surgical techniques have led urologists to perform nephron-sparing surgery (NSS) more frequently and also to extend its indication to elective conditions. We review the state of the art of NSS for RCC and report a multicentric experience at four Italian urologic departments. Methods: We used the Medline database to collect relevant reports on NSS. We critically reviewed and evaluated the data of patients who underwent open partial nephrectomy between 1994 and 2004 at four Italian urologic centres, namely, Genoa, Bologna, Trieste, and Savona. A final cohort of 360 patients, with a mean follow-up of 55.3 mo who underwent NSS mainly for elective conditions (72.1%), was statistically evaluated. Results: NSS is a successful treatment for patients with localised RCC for both elective and imperative conditions, providing the same excellent long-term results as radical surgery in selected patients. The surgical complications of NSS have continued to decline in the last three decades. In our population, the 5- and 10-yr cancer-specific survival rates were 96.6% and 86.9%, respectively. Conclusions: Open conservative surgery represents a safe and effective treatment for small renal tumours. New minimally invasive nephron-sparing techniques are currently being developed and will certainly evolve in the near future.
AB - Objectives: The natural history of renal cell carcinoma (RCC) has changed dramatically in the last two decades. The rising incidence of small renal lesions and advances in surgical techniques have led urologists to perform nephron-sparing surgery (NSS) more frequently and also to extend its indication to elective conditions. We review the state of the art of NSS for RCC and report a multicentric experience at four Italian urologic departments. Methods: We used the Medline database to collect relevant reports on NSS. We critically reviewed and evaluated the data of patients who underwent open partial nephrectomy between 1994 and 2004 at four Italian urologic centres, namely, Genoa, Bologna, Trieste, and Savona. A final cohort of 360 patients, with a mean follow-up of 55.3 mo who underwent NSS mainly for elective conditions (72.1%), was statistically evaluated. Results: NSS is a successful treatment for patients with localised RCC for both elective and imperative conditions, providing the same excellent long-term results as radical surgery in selected patients. The surgical complications of NSS have continued to decline in the last three decades. In our population, the 5- and 10-yr cancer-specific survival rates were 96.6% and 86.9%, respectively. Conclusions: Open conservative surgery represents a safe and effective treatment for small renal tumours. New minimally invasive nephron-sparing techniques are currently being developed and will certainly evolve in the near future.
KW - Kidney
KW - Minimally invasive
KW - Nephron-sparing surgery
KW - Renal cell carcinoma
KW - Survival rate
UR - http://www.scopus.com/inward/record.url?scp=33646569430&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646569430&partnerID=8YFLogxK
U2 - 10.1016/j.eursup.2006.04.002
DO - 10.1016/j.eursup.2006.04.002
M3 - Article
AN - SCOPUS:33646569430
SN - 1569-9056
VL - 5
SP - 600
EP - 609
JO - European Urology, Supplements
JF - European Urology, Supplements
IS - 8
ER -